Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021

doi:10.1001/jama.2021.1967

. 2021 Mar 16;325(11):1101-1102.

doi: 10.1001/jama.2021.1967.

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021

Tom T Shimabukuro¹, Matthew Cole², John R Su¹

Affiliations

¹ Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
² Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

PMID: 33576785
PMCID: PMC8890485
DOI: 10.1001/jama.2021.1967

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021

Tom T Shimabukuro et al. JAMA. 2021.

. 2021 Mar 16;325(11):1101-1102.

doi: 10.1001/jama.2021.1967.

Authors

Tom T Shimabukuro¹, Matthew Cole², John R Su¹

Affiliations

¹ Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
² Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.

PMID: 33576785
PMCID: PMC8890485
DOI: 10.1001/jama.2021.1967

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Cited by

Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database.
Karam R, Iskandar K, Watfa M, Zeitoun A. Karam R, et al. BMC Public Health. 2024 Oct 21;24(1):2905. doi: 10.1186/s12889-024-20297-z. BMC Public Health. 2024. PMID: 39434043 Free PMC article.
Behcet's disease-related panuveitis following COVID-19 vaccination: A case report.
Lin RT, Liu PK, Chang CW, Cheng KC, Chen KJ, Chang YC. Lin RT, et al. World J Radiol. 2024 Sep 28;16(9):460-465. doi: 10.4329/wjr.v16.i9.460. World J Radiol. 2024. PMID: 39355389 Free PMC article.
BAYESIAN LEARNING OF COVID-19 VACCINE SAFETY WHILE INCORPORATING ADVERSE EVENTS ONTOLOGY.
Zhao B, Zhong Y, Kang J, Zhao L. Zhao B, et al. Ann Appl Stat. 2023 Dec;17(4):2887-2902. doi: 10.1214/23-aoas1743. Epub 2023 Oct 30. Ann Appl Stat. 2023. PMID: 39282096 Free PMC article.
COVID-19: vaccination, therapeutics and a review of the science and public health.
Shah SK, Bhandari K, Shah A, Chaurasiya G. Shah SK, et al. Ann Med Surg (Lond). 2024 Jul 17;86(9):5343-5353. doi: 10.1097/MS9.0000000000002374. eCollection 2024 Sep. Ann Med Surg (Lond). 2024. PMID: 39239001 Free PMC article. Review.
Medical occurrence and safety of SARS-CoV-2 vaccination outside of the hospital setting.
Ferrari F, Sodi F, Madotto F, Carlesso E, Florio G, Pelliccia MR, Laquintana D, Bisesti A, Piatti A, Letzgus M, Tiwana N, Jachetti A, Mancarella M, Cereda D, Leoni O, Borriello CR, Chiappa L, Sottocorno M, Costantino G, Zanella A, Grasselli G. Ferrari F, et al. Intern Emerg Med. 2024 Sep;19(6):1593-1604. doi: 10.1007/s11739-024-03641-4. Epub 2024 Jul 23. Intern Emerg Med. 2024. PMID: 39042210

See all "Cited by" articles

References

1. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1922–1924. doi:10.15585/mmwr.mm6950e2 - DOI - PMC - PubMed
1. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1653–1656. doi:10.15585/mmwr.mm695152e1 - DOI - PMC - PubMed
1. Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0600 - DOI - PMC - PubMed
1. CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020-January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(4):125–129. doi:10.15585/mmwr.mm7004e1 - DOI - PMC - PubMed
1. McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141 (2):463–472. doi:10.1016/j.jaci.2017.12.971 - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
Medical
- MedlinePlus Health Information

[1] Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1922–1924. doi:10.15585/mmwr.mm6950e2 - DOI - PMC - PubMed

[2] Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1922–1924. doi:10.15585/mmwr.mm6950e2 - DOI - PMC - PubMed

[3] Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1653–1656. doi:10.15585/mmwr.mm695152e1 - DOI - PMC - PubMed

[4] Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1653–1656. doi:10.15585/mmwr.mm695152e1 - DOI - PMC - PubMed

[5] Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0600 - DOI - PMC - PubMed

[6] Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA. Published online January 21, 2021. doi:10.1001/jama.2021.0600 - DOI - PMC - PubMed

[7] CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020-January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(4):125–129. doi:10.15585/mmwr.mm7004e1 - DOI - PMC - PubMed

[8] CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020-January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(4):125–129. doi:10.15585/mmwr.mm7004e1 - DOI - PMC - PubMed

[9] McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141 (2):463–472. doi:10.1016/j.jaci.2017.12.971 - DOI - PMC - PubMed

[10] McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018;141 (2):463–472. doi:10.1016/j.jaci.2017.12.971 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021

Affiliations

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical